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CHAPTER I 
 
 
INTRODUCTION 
Background 
Drinking tea is a cultural pastime that has been around for centuries. Tea is 
derived from brewing leaves of Camellia sinensis in hot water. Along with water, tea 
(primarily green or black) is the most widely consumed beverage worldwide (Khan and 
Mukhtar, 2007). For centuries, many Asian cultures have relied on various forms of tea to 
treat an array of common medical problems including headache, indigestion, and 
dizziness.  
Green tea can be taken in various forms including beverage and extract. However, 
green tea is primarily utilized in the beverage form. Several studies have suggested that 
consumption of green and black tea beverages may result in favorable health benefits.  
The three primary forms of tea consumed are green, black, and oolong. The 
difference among these three forms of tea is in the processing. Green tea is made from 
freshly harvested leaves that have been promptly steamed to prevent fermentation (Khan 
and Mukhtar, 2007). Black tea, however, is made from leaves that have been fully 
oxidized prior to desiccation while oolong tea leaves are partially oxidized before drying 
(Khan and Mukhtar, 2007; Trevisanato and Kim, 2000). 
Green tea is a rich source of polyphenolic flavonoids, primarily catechins. 
Catechins are potent antioxidants (Coimbra et al., 2006). The key polyphenols in green 
 2 
tea consist of epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin 
(EC), and epicatechin gallate (ECG) (Chow et al., 2003). Of the catechins found in green 
tea, EGCG possesses the most anti-oxidative activity and is the polyphenol found most 
abundantly in green tea encompassing 50%-80% of the total catechin content of green tea 
(Khan and Mukhtar, 2007; Coimbra et al., 2006). Flavonoids are a class of antioxidants 
that are known to neutralize free radicals in the body. Free radicals are known to damage 
cells by oxidative stress (Trevisanato and Kim, 2000). Tea flavonoids are absorbed from 
the gut. Following absorption, tea flavonoids significantly increase the antioxidant 
capacity of the blood. This leads to increased antioxidant capacity of the body and the 
reduction of oxidative damage of important biomolecules (Rietveld and Wiseman, 2003). 
As a result, green tea may aid in decreasing oxidative stress.  
Oxidative stress is an imbalance between the production of free radicals and the 
antioxidant status of cells in the body (Forrester and Libby, 2007). When an individual is 
in an oxidative stress situation inflammation may follow. Inflammation is defined as a 
biological response to harmful stimuli. Internal balance is maintained by actively 
eliminating damaged cells. Vascular inflammation plays a central role in atherogenesis 
(Forrester and Libby, 2007). Chronic inflammation, which occurs when the body loses 
the ability to control inflammatory responses, may lead to an array of problems including 
atherosclerosis and arthritis. If green tea increases antioxidant capacity then inflammation 
should, consequently, decrease. Therefore, a healthy lifestyle along with medication, 
when appropriate, may avert the inflammatory process and thus promote healthy aging 
(Libby, 2006).  
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Introduction to Problem  
According to Hino et al., 2007 the occurrence of obesity is rapidly escalating in 
western countries and around the globe. Metabolic syndrome (MeS) is a cluster of risk 
factors associated with obesity. This cluster includes such factors as high blood pressure, 
abdominal obesity, hyperglycemia, and dyslipidemia. While the severity of each 
individual risk factor may be mild, the combination of 3 or more of the various risk 
factors is associated with increased cardiovascular morbidity and mortality. The 
development of metabolic syndrome is thought to be drastically influenced by lifestyle. 
For instance, the frequency of metabolic syndrome is lower in Japan where the beverage 
of choice is green tea. Therefore, it may be implied that the routine consumption of green 
tea is inversely associated with metabolic syndrome (Hino et al., 2007). Metabolic 
syndrome is associated with increased inflammation and oxidative stress (Hino et al., 
2007). There exists limited clinical data on green tea supplementation and oxidative 
stress and inflammation in subjects with metabolic syndrome.     
Few studies have looked primarily at the safety of green tea supplementation. The 
adverse effect that green tea has on iron absorption, due to tannins, has been questioned. 
However, few studies have reported the adverse effects of green tea supplementation. 
One concern of supplementation may be hepatoxicity when green tea is supplemented in 
high doses for an extended period of time (Basu and Lucas, 2007).  According to Chow et 
al., 2003 some unfavorable occurrences that have been reported during various studies 
include gas, upset stomach, nausea, heartburn, abdominal pain, dizziness, headache, and 
muscle pain. In the majority of cases, these events were reported as mild and did not 
occur any more in the supplemented group than in the placebo group. In previous studies, 
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it has been concluded that green tea supplementation should be considered safe for 
healthy individuals in doses equivalent to the EGCG content in 8-16 cups of green tea 
once or in divided doses twice a day for 4 weeks. All side effects seem to be dose 
dependent. The higher the dose of green tea administered the greater the chance of 
developing one or more of the minor health maladies, with special regards to nausea, 
bloating, and vomiting.  Caffeinated green tea supplementation may cause agitation, 
dizziness, insomnia, restlessness and tremors. No observational studies reported toxicity 
when green tea was consumed as a daily beverage. However, there is a need for further 
research on the safety of green tea supplementation in human subjects.   
Tea consumption in general, has been linked to low incidences of a collection of 
pathological conditions including CVD, diabetes, obesity and cancer. Drinking tea, 
especially green tea, daily is an inexpensive and low calorie approach to provide the body 
with powerful antioxidant protection. Overall, many studies have shown evidence to 
suggest that the health benefits of green tea supplementation may greatly outweigh the 
risks (Cooper, Morre, Morre 2005). However, there exists limited data on the safety of 
green tea supplementation in individuals with MeS and more studies are needed to 
determine the safety of green tea supplementation in these individuals.  
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Objective/Hypothesis 
The aim of the present study is to look at the correlation between chronic green 
tea supplementation and its effects on hematological profile and oxidative stress in 
subjects with MeS. We will also address the safety of chronic green tea supplementation 
in these subjects. Thus, our study will address the research gap on the safety of green tea 
supplementation and its effects on oxidative stress and safety in at-risk subjects and the 
role of green tea in medical nutrition therapy (MNT). The hypotheses to be tested include 
the following: 
• Green tea extract supplementation or green tea beverage will have no 
effects on safety parameters in individuals with MeS.   
• Green tea extract supplementation or green tea beverage will not lower 
biomarkers of oxidative stress in subjects with MeS. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
  The following review of literature focuses on several observational, cell culture, 
animal model and clinical studies that have analyzed the effects of green tea 
supplementation on hematology and oxidative stress as well as the safety parameters of 
green tea supplementation. This review also focuses on the effects of myloperoxidase on 
oxidative stress. 
Green Tea and Health Benefits 
  Green tea along with black and oolong are the three primary types of tea 
consumed worldwide (Popkin et al., 2006). These three forms of tea, which originate 
from the plant Camellia sinensis, are grown primarily in Southeast Asia as well as China 
and are consumed globally. Green tea can be utilized in several forms including 
beverage, dietary supplementation, and topical preparations. The major differences in the 
three forms of tea may be due to variations in the fermentation (oxidation) process. Green 
tea is in the form of fresh/dried unfermented leaves, black tea is fermented and oolong is 
incompletely fermented (Cooper, Morre and Morre, 2005).  
  There are several health benefits that may be attributed to tea consumption 
including an increase in bone density and a decrease in cavities and tooth decay (Popkin 
et al., 2006). Green tea may also produce antibacterial and antiviral activity. According to 
Craig, 1999 herbal remedies, such as green tea extract, are used by one out of every three 
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Americans to treat common ailments such as arthritis, headache, and depression (Craig, 
1999).  
  Tea is a diverse substance that is comprised of flavonoids, antioxidants, 
micronutrients, and a few amino acids (Popkin et al., 2006). The flavonoids in green tea 
have anti-inflammatory properties (Craig, 1999). Flavonoids act as antioxidants and 
prevent tissue damage by the scavenging of free radicals (Trevisanato and Kim, 2000). In 
a previous study, green tea was shown to have ~4.5-6% greater antioxidant capacity than 
the antioxidant rich kale and strawberries (Cao, Sofic and Prior, 1996). The potent 
antioxidant compounds in tea may protect low-density lipoprotein (LDL) cholesterol 
from oxidation and inhibit lipid peroxidation (Craig, 1999).   
  Decaffeinated green tea (brewed) contains around 3mg of caffeine compared to 
caffeinated green tea with approximately 30mg per 8 fl oz. The suggested daily 
consumption of tea per day is roughly 28 fl oz while the average consumption is 36 fl oz 
(Popkin et al., 2006). Green tea is inexpensive, provides ~0kcal per serving, has not 
shown any significant side effects, provides several health benefits, and previous data has 
indicated that it is safe in recommended amounts for daily use (Trevisanato and Kim, 
2000). However, the use of green tea extracts, along with any other herbal remedy, needs 
to be further investigated to determine their safety (Craig, 1999). The major polyphenols 
in green tea are EGCG, EC, EGC, and ECG which belong to the family of catechins 
(Cooper, Morre and Morre, 2005) with EGCG being the most abundant in green tea 
(90mg/cup) and therefore regarded as the most important green tea catechin in the 
production of green tea extracts for dietary supplementation (Wang, Provan and 
Helliwell, 2000).  
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Observational Studies 
  Green tea supplementation has been shown to promote weight loss which may in 
turn have a positive effect on metabolic syndrome (Cooper, Morre and Morre, 2005). 
Metabolic syndrome is a cluster of risk factors (dyslipidemia, high blood pressure, 
hyperglycemia, abdominal obesity, etc.) associated with an increase in incidence of 
certain disease states including cardiovascular disease and type 2 Diabetes Mellitus 
(DM). Each individual risk factor may be a mild indicator; however, the cluster of risk 
factors is associated with increased morbidity and mortality.  Until recently the frequency 
of metabolic syndrome has been lower in Japan than in western countries. Green tea is 
the drink of choice in Japan. Due to westernization there has been a decrease in green tea 
consumption and an increase in metabolic syndrome Hino et al., 2007. Hino et al., 2007 
analyzed the relationship between habitual green tea and coffee drinking and their 
relationship to metabolic syndrome in the general Japanese population. Food frequency 
questionnaires were completed by each individual participant to obtain dietary habits.  
This data was compared to data obtained from a National Nutrition Survey that was 
completed in 1999. More participants consumed green tea than coffee. In this study, no 
relationship was found between green tea consumption and metabolic syndrome (Hino et 
al., 2007).   
  Green tea consumption has been attributed to a decrease in the risk of 
cardiovascular disease. The consumption of green tea may lower LDL cholesterol and 
reduce the risk of myocardial infarction. Furthermore, moderate green tea consumption 
has been shown to have a hypolipidemic effect, due to the catechin content, and inhibit 
LDL oxidation in humans (Cooper, Morre and Morre, 2005). Green tea 
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consumption/supplementation has also been shown to have anti-inflammatory properties 
which may lead to a decrease in cardiovascular disease since inflammation plays an 
important role in atherogenesis Forrester and Libby, 2007. Inflammation is the body’s 
natural immune response to external agents in an attempt to maintain internal balance 
(Forrester and Libby, 2007). The reduction of inflammation can be achieved through 
antioxidant rich foods, such as green tea. A decrease in inflammation plays a key role in 
the decrease in the risk of cardiovascular disease.  
Cell Culture 
Tea polyphenols are potent antioxidants that provide benefits against oxidative 
stress through the increase of antioxidant defense and scavenging of reactive oxygen 
species (Raza and John, 2005). Green tea has been reported to have anti-oxidative 
properties and has been shown to inhibit lipoxygenase and promote LDL oxidative 
modification in vitro (Yang and Koo, 2000).  EGCG, which is a major catechin in green 
tea, has been shown to aid in the prevention of copper (Cu+) induced LDL oxidation 
(Miura et al, 1994) and anti-oxidants provide protection to LDL oxidation. It has been 
shown that oxidized LDL can be an initiator/promoter of atherogenesis. Cholesterol 
oxidation and lipoprotein oxidation are enhanced through oxygen radicals that are 
generated by lipid peroxidation and Cu+ mediated LDL oxidation.  
In a study by Miura et al, 1994 fresh whole blood samples were taken from 
normolipidemic males and LDL was separated, concentrated, and then catalyzed by Cu+. 
The investigators found that antioxidant potency was greatest in EGCG followed by 
ECG. These catechins had the greatest inhibitory effects on Cu+ catalyzed LDL oxidation 
and the inhibition of oxidized cholesterol. EGCG has two triphenolic groups in structure 
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and EGCG and ECG both have galloyl moieties which may account for their enhanced 
antioxidant activities. Catechins were also shown to inhibit the increase of lipid 
peroxidation in the Cu+ catalyzed LDL oxidation.   
In a study by Ishikawa et al., 1997 catechins were added to plasma of 
normolipidemic healthy males, incubated, and the LDL fraction was separated.  
Oxidation of LDL was measured by conjugated dienes and lipid peroxides, thiobarbituric 
acid-reactive substance (TBARS). The study found that catechins significantly and dose- 
dependently prolonged the lag time of LDL oxidation. EGCG had the greatest effect in 
prolonging the lag time and, along with ECG, had the strongest effects on oxidative 
stress.  The decrease in TBARS and lipid peroxide formation was observed in LDL 
samples in which green tea catechins were added (Ishikawa et al., 1997).  
When Raza and John, 2005 investigated the effects of EGCG on PC12 cell 
compartments, they found a positive alteration in oxidative stress of the cell 
compartments. The catechins in green tea act as free radical scavengers and have been 
shown to inhibit the activity of lipoxygenase and inhibit Cu+ induced LDL oxidation.  
Lung Chen tea, which is a non-fermented Chinese green tea, has the highest 
concentration of catechins and EGCG among the green teas (Yang and Koo, 2000). A 
study which analyzed the effect of Lung Chen tea on LDL oxidation in endothelial cells 
found that this tea inhibited LDL oxidation in vitro (Yang and Koo, 2000). In addition, 
Lung Chen tea dose-dependently lowered lipid peroxidation products (Yang and Koo, 
2000). In vitro studies have primarily shown that the effects of green tea on oxidative 
stress and lipid peroxidation are dose-dependant, with EGCG being the primary 
contributor (Miura et al., 1994).  
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Animal Studies 
Green tea leaves are high in polyphenols along with many other compounds 
including, aluminum (Marouani et al., 2007). Polyphenols found in green tea may lead to 
a decrease in iron status; however, the correlation is unclear. Green tea decoction, which 
is obtained by cooking dried tea leaves for an extended amount of time, may be a cause 
of iron deficiency anemia. Green tea decoction may cause an increase in aluminum and 
/or the formation of insoluble complexes in the gastrointestinal lumen. An increase in 
aluminum may lead to less availability of iron for absorption. This is due to the fact that 
iron and aluminum compete at different stages of erythropoiesis for storage.  
In an 8 week study by Ishige, Schubert and Sagora, 2001, 42 male Wistar rats (2 
months old) were divided into 6 random groups with 7 rats in each group. A control 
group was given an experimental diet and water, while the remaining groups were given 
the experimental diet and various amounts of green tea decoction and aluminum. This 
study, also showed, that a decrease in iron stores in organs which led to a decrease in 
overall iron status was a directly correlated to aluminum absorption and low iron status 
along with a decrease in hemoglobin (9%) and hematocrit (7%) (Ishige, Schubert and 
Sagora, 2001).   
Green tea may decrease circulating lipids in body fluids which may reduce 
oxidative stress in the body. Researchers state that a redox balance exists in organisms 
and changes in the antioxidant status of the body may disrupt this balance. Oxidative 
stress may be induced for a variety of reasons including alcohol-abuse, exercise, age, and 
various disease states such as diabetes mellitus and metabolic syndrome. A reduction in 
antioxidant status may also lead to oxidative stress. Oxidative stress may lead to cellular 
 12 
oxidation. This may lead to dyslipidemia and an enhancement in the aging process. In a 
study analyzing the effect of green tea on oxidative stress in diabetic rats, it was found 
that lipid peroxide levels decreased significantly as the antioxidant status improved (Babu 
et al., 2006). It was also found that there was an inverse relationship with food intake and 
treatment inhibited weight loss (Babu et al., 2006). Tuczaj et al., 2004 analyzed the effect 
of ethanol-induced oxidative stress in male Wistar rats and found that oxidative stress 
was lowered when green tea was ingested. Furthermore, the amount of lipid peroxidation 
products decreased. Green tea prevented oxidative modification by increasing antioxidant 
status. This was achieved by a synergy within green tea catechins, the most potent being 
EGCG. In addition, oxidation was decreased in the serum of ethanol-fed Wistar rats. 
Alessio et al. 2002 investigated exercise induced oxidative stress (in the kidney and liver) 
in male Sprague-Dawley rats that consumed green tea for 6.5 weeks. Results showed that 
green tea had no significant effects on measured physiological parameters including 
glucose and cholesterol but did decrease the accumulation of lipid peroxide products in 
the kidney. 
MPO  
Myeloperoxidase (MPO) is used as a marker of inflammation and may be 
responsible for oxidative stress in several tissues. Liu et al. 2005, investigated the effect 
of lycopene, and antioxidant, on exercise induced oxidative stress in male Sprague-
Dawley rats. MPO in the muscle of the exercise group was significantly higher (30%) 
than that of the control. In addition, MPO activity was significantly lower in the muscle 
of the exercise group that was given the highest dose of lycopene. This suggests that 
antioxidant status may decrease MPO activity during exercise induced oxidative stress. 
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Therefore, antioxidants may decrease oxidative damage by decreasing MPO activity. 
MPO is an enzyme that is found in neutrophils, monocytes and macrophages. The level 
of MPO activity that is present in a suspension of neutrophils is directly proportional to 
the number neutrophils over a wide range of concentrations. Krawisz et al. 1984, used 
MPO activity to assess inflammation in two animal models (acetic acid induced colitis in 
the rat and Clostridium difficile induced enteritis in the hamster). MPO was found to have 
a have a liner relationship with the number of neutrophil cells in purified cell populations. 
Therefore, MPO may reflect the level of inflammation in intestinal mucosa and MPO 
activity should provide an estimation of the average level of inflammation. MPO 
determinations are simple for use in large populations and could be useful as a marker of 
inflammation in human and animal models. However, the effects of green tea 
polyphenols on MPO have not been clearly investigated and there is a further need for the 
investigation of MPO in subjects with MeS.     
Clinical Trials 
  Green tea supplementation has been has been shown to cause a decrease in 
oxidative stress 9Coimbra et al., 20060. Changes in oxidative stress appear to be related 
to dietary habits, lifestyle, and to the experimental protocol used in each study. In a study 
by Coimbra et al., 2006 individual parameters of oxidative stress were evaluated after 
drinking 1 liter of water daily for 3 weeks followed by drinking 1 liter of green tea daily 
for 4 weeks. Subjects were advised to drink the assigned beverages throughout the day 
and maintain their usual food and drink patterns at mealtime. Blood samples were 
collected at rest and fasting for 12 hrs after 3 weeks of water daily and 4 weeks of green 
tea daily. In addition, colorimetric assay was used to evaluate total antioxidant status. 
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This study measured total antioxidant status (TAS), malonyldialdehyde (MDA), and 
malonyldialdehyde+4-hydroxy-2(E)-nonenal (MDA+4-HNE). There was a significant 
decrease in membrane bound haemoglobin (MBH) suggesting reduced oxidative stress 
within the cell (Coimbra et al., 2006).  
  Tea consumption has been associated with a decrease in the incidence of chronic 
diseases in which oxidative stress plays a key role. In a study by Erba et al., 2005 
involving 24 healthy females, 20-29 yrs old with an average BMI of 19, were 
evenly/randomly divided into two groups (control and green tea supplementation). The 
study lasted for 42 days. The supplemented group consumed a cup of green tea with 
breakfast and a cup of green tea with dinner (160mg green tea extract with 200ml of 
water). Both groups maintained a controlled diet throughout the study. Blood samples 
were taken at the beginning and end of the study. This study showed a slight decrease in 
LDL as compared to the control group and an improved plasma antioxidant status. The 
mean plasma concentration of green tea catechins was also above the baseline average 
when green tea is consumed regularly. This increased plasma concentration of 
EGCGremained for at least 12 hrs after ingestion. This study suggests increased plasma 
antioxidant status and protection of lymphocytes from DNA oxidative damage following 
moderate green tea consumption (Erba et al., 2005).  
  LDL oxidation plays an essential function in atherogenesis. In previous studies 
green tea polyphenols have been shown to inhibit the oxidation of LDL (Miura et al., 
2000). Catechins (primarily EGCG) may play a role in the inhibition of LDL oxidation. 
When EGCG gets absorbed in the plasma at a maximum concentration, this may lead to 
increased antioxidant activity in the bloodstream (Nakagawa et al., 1999).  Miura et al., 
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2000 found that the lag time of LDL oxidation was prolonged approximately 14 minutes 
following the ingestion of 300mg of green tea polyphenol extract. This same study found 
that 56% of EGCG in the free form remained in the plasma following a blood draw one 
hour following ingestion of the green tea extract (Miura et al., 2000). Another study by 
Nakagawa et al., 1999 reported similar results stating green tea extract (254mg catechins) 
significantly increased the plasma EGCG concentration in humans 60 minutes following 
ingestion (Nakagawa et al., 1999). Studies have shown that tea phenolics may produce 
considerable antioxidant activity and in turn neutralize free radicals. One study which 
investigated the ingestion of various phenol-rich beverages found that 300ml bolus of 
green tea (along with red wine) was the most efficient in protection of LDL oxidation 
(Serafini et al., 2000). However, green tea alone showed maximum decrease in LDL 
oxidation 30 minutes after ingestion (Serafini et al., 2000).   
  There is evidence to suggest that tea is a hypoglycemic agent. It is suggested that 
catechins and theaflavins may enhance insulin activity which may aid in the prevention 
of hypoglycemia. One study looked at the effects of tea extract supplementation on 
glucose control in 49 individuals (49-86 yrs old) with recently diagnosed (past 6 months) 
type 2 diabetes mellitus and without insulin treatment (Mackenzie, Leary and Brooks, 
2007). After randomization, subjects received one of the 4 regimens which included; 2 
capsules per day of extract, 1 capsule per day of extract, 2 capsules per day of placebo, or 
1 capsule per day of placebo for3 months. The extract contained green tea catechins 
(40%) and black tea theaflavins (20%); equivalent to the catechins of 7 cups of green tea. 
Adverse events included profuse sweating and a rash. No significant improvements in 
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HbA1c were observed suggesting that tea extracts may not have a positive effect on 
glucose control in individuals with type 2 DM (Mackenzie, Leary and Brooks, 2007). 
  The safety of green tea supplementation needs to be determined to make the 
utilization of green tea in interventions a viable option. A study by Chow et al., 2003 
investigated the safety/pharmacokinetics of green tea supplementation. Multiple doses of 
epigallacetechin gallate and polyphenol E were given to 40 healthy individuals (men and 
women) over 18 years of age. The polyphenon E capsules consisted of EGCG (200mg), 
EGC (37mg), EC (31mg), and other green tea polyphenols along with minimal structural 
ingredients. Caffeine was not present in either the EGCG capsules or the polyphenon E 
capsules. Fasting blood samples were taken from the subjects before and after the 4 week 
treatment period. The laboratory analysis included glucose, urea nitrogen, creatinine, total 
protein, albumin, alkaline phosphatase, total billirubin, and iron. One of five treatments 
(800 mg EGCG once daily, 400 mg EGCG twice daily, 800 mg EGCG polyphenon E 
once daily, 400 mg EGCG polyphenon E twice daily, of a placebo once daily) were given 
for 4 weeks after an initial 2 week period free of tea, tea products, dietary and herbal 
supplements. The study participants were then followed for 4 weeks and any adverse 
reactions were documented. Reported events included excess gas, upset stomach, nausea, 
dizziness, headache, etc. However, all reported events were not significantly greater than 
in the placebo group and all events were reported as mild. Nausea did increase, however, 
as the dosage of EGCG increased to 800 mg.  No significant changes were observed in 
hematology. Overall, the study concluded that green tea polyphenol supplementation is 
safe for healthy individuals in doses equivalent to 8-16 cups of green tea per day (Chow 
et al., 2003).   
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  This review of literature focused on several observational, cell culture, animal, 
and clinical studies which looked at the safety of green tea beverage and supplement 
along with the lowering effect that green tea has on oxidative stress and inflammation. 
However, there seems to be a gap in knowledge with regards to the safety of green tea 
beverage and supplement in subjects with MeS. There is also a gap in knowledge with 
regards to green tea and its lowering effects on oxidative stress and inflammation in 
subjects with MeS. The following study looks at the effect of green tea beverage and 
supplement on oxidative stress by measuring LDL oxidation and MPO in subjects with 
MeS. Furthermore, this study looks at the safety of green tea beverage and supplement in 
these individuals.  
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CHAPTER III 
 
 
METHODOLOGY 
Subjects 
 
 Twenty-eight subjects (n=28) with MeS were enrolled in the study between 
January 2007 and January 2008. According to the National Cholesterol Education 
Program (NCEP) Adult Treatment Panel III (ATP III) criteria, MeS is defined as having 
any three of the following five features: waist circumference (≥40 inches in men & ≥35 
inches in women), triglycerides ≥150 mg/dL, HDL (<40 mg/dL in men; < 50mg/dL in 
women), blood pressure ≥130/85mm Hg, and fasting glucose (≥100mg/dL). Adult 
subjects (> 21 years) with normal hemoglobin (Hb), white blood cells (WBC), platelets, 
liver, renal, and thyroid function tests, and on stable medications were included in the 
study. Smokers, heavy drinkers (> 1 oz alcohol/day), those taking mega doses of 
antioxidants or fish oil supplements (> 1g/day), along with individuals who had a history 
of cancer, coronary heart disease, or type 2 diabetes were excluded from the study. 
Subjects were asked to abstain from consuming green tea or green tea-related products, 
other than those provided in the study, and maintain usual diet and lifestyle throughout 
the study period. All subjects were screened with a complete medical history and signed 
the informed consent form.   
 The study examined the effects of green tea (GT- 4 cups/day), green tea 
supplement (GS- 2 capsules, 500 mg EGCG, 4 cups water/day), and control (C- 4 cups 
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water/day) on clinical variables (fasting glucose, insulin resistance, lipid profile, 
complete blood count, liver, renal, and thyroid function tests), and biomarkers of 
oxidative stress in this eight-week, randomized controlled trial.  
 Age and sex-matched trios of participants with MeS were randomly assigned to 
one of three groups. The study was conducted at the University of Oklahoma Health 
Sciences Center (OUHSC), General Clinical Research Center (GCRC). A total of 5 clinic 
visits (screening and follow-up visits at 2, 4, 6, & 8 weeks) were conducted for all 3 
groups. However, subjects in the green tea group made daily visits (5 days/week) to the 
GCRC for a fresh supply of tea, especially to ensure compliance and consistency. The 
green tea group consumed 2 cups of green tea in the morning at GCRC and were 
provided with another 2 cups in a container and asked to consume later in the day (6-8 
hours later). Tea was also provided for the weekends. The Bionutrition unit at GCRC, 
headed by the research dietitian, prepared the green tea for the subjects and monitored 
compliance.  
 Those in the control and supplement groups were provided with containers to 
measure 4 cups of water to be consumed on a daily basis. Participants in the supplement 
group received a 2-week supply of capsules during their follow-up visits and compliance 
was confirmed by a pill count.  Participants were instructed to take 2 capsules a day, one 
capsule with lunch and dinner. Fasting blood draws and anthropometric measurements 
were performed at screening, four and eight weeks of the study. All participants were 
compensated at screening and bi-weekly follow-up visits.  
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Supplements 
Decaffeinated green tea supplements were purchased from Solaray® (Park City, 
UT). The capsules were manufactured from the same lot numbers of raw materials and 
the label claimed 500 mg of green tea extract providing 250 mg of EGCG. Other 
ingredients in the capsule and filler included vegetable cellulose, magnesium stearate and 
silica.  
Tea preparation 
 Green tea bags (from one production lot) were purchased from RC Bigelow Inc.© 
(Fairfield, CT).  Green tea was prepared by trained Bionutrition staff at OUHSC GCRC 
by steeping 4 decaffeinated green tea bags in 4 cups of boiling water (8 oz/cup) for 10 
minutes. No sugar or milk was added to the tea, but according to the preference of the 
participants, artificial sweetener may be used. The subjects consumed 2 cups at GCRC 
while being monitored, and the remaining 2 cups were provided in a container. 
Participants were told not to reheat the tea which they consumed later in the day, but 
drink it straight from the container. Subjects received 100 mg of EGCG per cup of green 
tea and 400 mg of EGCG per day. Catechin analyses were performed in the Human 
Nutrition Laboratory at OSU.   
Sample collection and storage 
 Fasting blood samples taken by a certified phlebotomist were collected at 
screening, and after 4 weeks and 8 weeks. Blood samples were collected in heparinized 
tubes, in vials containing EDTA, and serum separator tubes (SST). Serum and plasma 
samples were separated, flushed with nitrogen, and stored at -80° C for later analysis.  
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Biochemical analyses 
 Blood samples were collected immediately after each draw at GCRC and 
transported to the University of Oklahoma Medical Center (OUMC) Laboratory for 
analyses of fasting glucose, lipid profile {total cholesterol, triglycerides, low-density 
lipoproteins (LDL), high density lipoproteins (HDL)} and safety parameters including 
hemoglobin (Hb), platelets, white blood cells (WBC), liver enzymes, creatinine, and 
blood urea nitrogen (BUN) were analyzed. ELISA was performed for the analyses of 
oxidized LDL and myeloperoxidase (MPO).  
Oxidized LDL assay 
Mercodia Oxidized LDL (Mercodia Uppsala Sweden) competitive ELISA was 
used to determine LDL oxidation. A fixed amount of oxidized LDL is bound to the 
microtiter well. This oxidized LDL competes with the oxidized LDL in the sample. The 
absorbance was then measured at 450 nm and read spectrophotometrically Data was 
analyzed using a calibration curve for each assay. 
MPO ELISA  
 MPO is an iron containing glycoprotein that is traditionally used as a marker of 
inflammation. MPO plays a potential role in atherosclerosis and therefore may be a 
marker of cardiovascular disease (CAD). Plasma levels of MPO were determined by 
commercially available ELISA (Mercodia Uppsala Sweden) using the manufacturers 
instruction. 
Statistical analyses 
 The data was first graphed to identify outliers and/or errors. The student’s t-test 
for two independent groups was applied to address any differences between groups at 
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baseline. A P value of <0.05 was considered statistically significant. Initially, the subjects 
were randomized to trios by age and gender. However, due to imbalance and 
incompletion within trios due to a small sample size, the data was analyzed by group. 
Changes from zero to eight weeks were assessed within groups with the paired t-test. 
Two sample t-tests were applied to measure changes from zero to eight weeks between 
groups. Due to sample size, the data was not corrected for multiple hypotheses testing. 
Instead, the data was reviewed for consistencies.    
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CHAPTER IV 
 
 
RESULTS 
 
Baseline Characteristics 
  
 A total of 28 subjects completed this randomized 8 week study. Three men and 
twenty-five women were enrolled and completed this study. There were 12 subjects in the 
control group, 11 subjects in the green tea beverage group, and 5 subjects in the 
supplement group. The baseline characteristics of these subjects are depicted in Table 1. 
As depicted in Table 1, the BMI in all groups was greater than 30 which is an indicator of 
significant obesity. Waist circumference was high in all three groups. Triglycerides were 
greater than 150 mg/dL in the green tea beverage group alone. However, there was not a 
significant difference between groups. Control and green tea supplement groups had a 
triglyceride level less than 150 mg/dL on average. HDL cholesterol was low in all three 
groups. Blood pressure was not high in any group but the majority of subjects were on 
blood pressure medication. All subjects were matched well based on age. The mean age 
in all groups was between 40-50 years. There were no statistically significant differences 
in baseline characteristics among the three groups.  
Body Weight and BMI 
 
 The change in body weight (Figure 1) and BMI (Figure 2) were significantly 
greater in the green tea group (p<0.05), when compared to the controls. Weight decreased 
by an average of 1.9 kg and BMI by 0.7 in the green tea group. The supplement group 
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experienced a loss of 1.3 kg and BMI decreased by 0.4, which was not significant 
compared to controls (Figure 1 and Figure 2). The control group showed a slight increase 
in both body weight (Figure 1) and BMI (Figure 2) at the end of this 8 week study.   
Safety Parameters and Hematology 
  
 Blood draws were done by a certified phlebotomist at screen, 4 weeks, and 8 
weeks. At screening, subjects with abnormal hematology, liver function or renal function 
tests were excluded from the study. The safety parameters analyzed in this study were 
liver function tests {alanine transaminase (ALT), aspartate transaminase (AST), and total 
bilirubin (TBIL} along with renal function {blood urea nitrogen (BUN) and creatinine 
(Cr)}. Total bilirubin decreased in both the control and green tea beverage group while 
there was no change seen in the supplemented group. However, this decrease was not 
statistically significant. There was a non-significant decrease in AST in both the green tea 
beverage and supplement groups while an increase was shown in the control. Both AST 
and ALT remained within normal limits from screening to 8 weeks. There was an 
increasing trend in BUN in all groups while Cr increased in the control group and green 
tea beverage group with no change seen in the supplement group at 8 weeks when 
compared to baseline. However, all groups were within normal limits with regard to renal 
function (BUN=7-18mg/dL and Cr = females-0.7-1.2 mg/dL and males-0.8-1.2mg/dL) 
which may indicate that green tea beverage or supplement had no harmful effects on 
renal function. Other hematological parameters addressed in this study were WBC, RBC, 
Hb, HCT, MCV, and PLT all of which were within normal limits at both baseline and 
8weeks. However, there was an increase in platelets within the supplement group versus 
the control group (p<0.05). The lack of change in most of the safety parameter and 
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hematology, except platelets, at 8 weeks when compared to baseline or control group is a 
good indication that green tea beverage and supplements are safe for use in subjects with 
MeS. Furthermore, no adverse events were reported with green tea beverage or 
supplement during this 8 week clinical trial.  
Biomarkers of Oxidative Stress 
 
LDL Oxidation 
  
 In this study ox-LDL was used as a measurement of oxidative stress in the 
subjects. There was a significant decrease in ox-LDL in the green tea group at 8 weeks 
when compared to baseline (p<0.05). This decrease in the green tea group was non-
significant in comparison to controls. However, this is still an indication that green tea 
beverage has a positive effect in lowering oxidative stress in subjects with MeS. A non-
significant increase in ox-LDL was seen in the supplement group at 8 weeks when 
compared to baseline. Therefore, the green tea beverage, not supplement, caused a 
significant decrease in ox-LDL at baseline compared to 8wks, but not in comparison to 
controls (Figure 3).  
MPO 
The green tea group showed a decreasing trend in MPO levels compared to 
controls (p<0.1). Interestingly, the green tea beverage group showed a significant 
decrease in MPO when compared to the supplement (p<0.05). The supplement group 
showed no significant decrease in MPO levels and the control group showed a non-
significant increase in MPO levels. Thus, green tea beverage intake showed a decreasing 
trend in MPO levels when compared to controls (p<0.1) (Figure 4).   
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Table 1  
         
Baseline Characteristics of all Study Participants by Treatment Group  
 
         
Variable  
 
Control (n=12) 
 
GT (n=11) 
 
GS (n=5) 
 
         
Age (years)  44.6± 3.2  45.3±3.0  40.0±4.2  
Male (n)  1  1  1  
Female (n)  11  10  4  
Body weight (kg) 102.7±6.6  100.8±5.8  116.5±8.3  
BMI  36.4±2.8  36.9±2.0  41.5±2.1  
Waist circum. (in) 42.5±1.9  43.0±1.5  49.7±3.7  
TG (mg/dL)  129.2±21.1  168.0±27.1  148.4±38.4  
HDL (mg/dL)  41.8±1.9  41.7±2.1  35.6±3.2  
SBP (mm/he)  129.8±2.6  133.5±4.8  127.4±6.4  
DBP (mm/he)  79.6±2.1  81.9±2.5  80.8±2.7  
Medication users (%) 45.4  85.7  60  
         
(Mean±Standard Error) 
 
GT-green tea, GS-green tea supplement, BMI-body mass index, TG-triglycerides,  
HDL-high density lipoprotein, SBP-systolic blood pressure, DBP-diastolic blood pressure 
         
 No statistically significant differences between groups (p>0.05)    
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Table 2 
 
         
 
        
Effect of Green Tea Supplementation on Hematology and Safety Parameters of all Study Participants  
 
         
         
Variable 
 
Control (n=12)  GT (n=11) GS (n=5) 
  
  
0wk          8wk 
 
0wk          8wk 
 
0wk       8wk 
  
WBC (K/mm3) 6.3±0.4           6.0±0.3   6.6±0.5          6.9±0.4  7.8±0.6           9.2±1.3   
         
RBC (K/mm3) 4.5±0.1          4.4±0.1  4.5±0.1         4.5±0.1  4.9±0.2          4.9±0.3   
         
Hb (g/dL)  13.5±0.3       13.3±0.3  13.3±0.2       13.2±0.2  14.5±0.7       14.5±1.0    
         
HCT (%)  39.8±0.9       39.1±0.9  39.0±0.7       38.7±0.5  42.2±2.0       42.5±3.0   
         
MCV (fL)   89.2±1.0       88.8±1.0  86.7±1.0       86.2±0.8  85.6±1.5       86.1±1.6   
         
PLT (K/mm3) ** 265.0±17.5   264.8±19.8 310.9±21.1    317.4±19.4 351.4±19.3    389.2±11.6  
         
BUN (mg/dL) 11.3±1.1        12.6±0.8  10.0±0.8       11.1±0.3  10.0±0.9       12.4±1.9   
         
Cr (mg/dL)  0.8±0.0          0.9±0.0   0.7±0.1          0.8±0.0   0.8±0.1          0.8±0.1   
         
AST (Units/L) 26.7±3.2        31.3±5.7  23.4±2.1       23.2±1.4  26.8±6.3       20.8±1.8   
         
ALT (Units/L) 34.8±6.9        34.5±6.9  24.0±2.3       27.9±4.0  33.4±9.9       25.4±4.6   
         
TBIL (mg/dL)  0.7±0.0          0.6±0.0  0.6±0.0          0.5±0.0  0.8±0.3          0.8±0.2   
         
(Mean±Standard Error)  
       
GT-green tea, GS-green tea supplement, WBC-white blood cells, RBC-red blood cells, Hb-hemoglobin 
HCT-hematocrit, MCV-mean cell volume, PLT-platelet, BUN-blood urea nitrogen, Cr-creatinine,   
AST-aspartate transaminase,  ALT-alanine transaminase, TBIL-total bilirubin    
         
* p<0.05, change significantly different from control   
**      indicated significance {Control-(-0.2), GT-(6.5), **GS-(37.8)}   
    
 
 
 
 
 
 
 28 
Figure 1 
 
Effect of Green Tea Supplementation on Body Weight Change of Participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Mean±Standard Error) 
 
C- Control, GT- Green tea, GS- Green tea supplement 
 
 *p<0.05 compared to controls 
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Figure 2 
 
Effect of Green Tea Supplementation on BMI of Participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Mean±Standard Error) 
 
C- Control, GT- Green tea, GS- Green tea supplement 
 
 *p<0.05 compared to controls 
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Figure 3 
 
Change in oxidized-LDL in Participants by Treatment Group  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Mean±Standard Error) 
 
C- Control, GT- Green tea, GS- Green tea supplement 
 
 *p<0.05 compared to baseline 
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Figure 4 
 
Change in myeloperoxidase (MPO) in Participants by Treatment Group  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Mean±Standard Error) 
 
C- Control, GT- Green tea, GS- Green tea supplement 
  
*p<0.1 compared to control, p<0.05 compared to supplement 
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CHAPTER V 
 
 
CONCLUSION 
Discussion  
  
The current study investigated the effects of green tea flavonoid supplementation 
on hematology, safety parameters, and oxidative stress in obese middle-aged subjects 
with MeS. Decaffeinated green tea beverage (4 cups/day) and green tea supplement 
(500mg EGCG/day) was used in the present study.  The tea was decaffeinated to avoid 
any conflicting variations that caffeine may have on the parameters tested.  Recorded 
clinic visits and pill counts helped in the determination of a high participant compliance 
rate.  
 There were no statistically significant differences in age and markers of MeS 
among the three groups at baseline (Table 1). At the end of the study, the changes in 
weight and BMI were significantly greater in the green tea group (p<0.05), when 
compared to the controls. One of the important findings of our study lies in the fact that 
weight decreased by and average of 1.9 kg and BMI by 0.7 in the green tea group with 
was significantly different from controls. The supplement group, however, exhibited a 
decreasing trend, compared to controls (p<0.1). Therefore, it is probable that with a 
longer study duration green tea beverage and supplement would have caused weight loss 
decreased BMI.  According to Cooper et al., 2005 green tea supplementation has been 
shown to promote weight loss which may in turn have a positive effect on metabolic 
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syndrome. However, Hino et al., 2007 found no relationship between green tea 
consumption and metabolic syndrome when analyzing the relationship between habitual 
coffee and green tea supplementation in the general Japanese population. Thus, green tea 
beverage intake may help promote weight loss specifically in obese subjects with 
metabolic syndrome. 
Safety parameters (liver function and renal function tests) were also investigated 
in this study.  There was a non-significant decrease in total bilirubin in both the control 
and green tea beverage group while there was no change seen in the supplemented group. 
In addition, there was a non-significant decrease in AST in both the green tea beverage 
and supplement group while an increase was shown in the control. Both AST and ALT 
remained within normal limits throughout the duration of the study.  This may suggest 
that green tea beverage and supplement is safe for use in individuals with MeS. 
All groups were within normal limits with regard to renal function which may 
indicate that green tea beverage or supplement had no harmful effects on renal function. 
There were no significant changes in safety parameters during this 8 week study. The 
lack of change in most of the safety parameters in this study show that green tea beverage 
(up to 4 cups/day) and supplement (up to 500mg EGCG per day) may be safe for use in 
individuals with MeS. Furthermore, no adverse events were reported with green tea 
beverage or supplement during this 8 week clinical trial which is also an indication of 
safety. However, the small sample and short study duration may explain the fact that no 
significant differences were noted in the safety parameters. When Chow et al., 2005 
investigated the safety/pharmacokinetics of green tea supplementation for weeks, they 
found that green tea polyphenol supplementation is safe for healthy individuals in doses 
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equivalent to 8-16 cups of green tea per day. The reported adverse events noted by Chow 
et al. included excess gas, upset stomach, nausea, dizziness, and headache. However, 
these events were mild and not significantly more than the placebo group which was an 
indication of safety and are in concordance with the findings of our study.       
        Hematological parameters included in this study were WBC, RBC, Hb, HCT, 
MCV, and PLT all of which were within normal limits at both baseline and 8 weeks.  
However, there was an increase in platelets within the supplement group versus the 
control group. This could be due to a wide variety of factors including medication use, 
hydration status and the small sample size in this group. It should however be noted that 
the increase was within the normal range of platelets. The lack of change in most of the 
hematology, except platelets, at 8 weeks when compared to baseline is a further 
indication that green tea beverage and supplement are safe for use in subject with MeS. 
According to Chow et al., 2003 no changes in hematology were observed during a 4 
week study period when participants were given either 800 mg once a day or 400 mg 
twice a day of EGCG or EGCG as polyphenon E. 
Biomarkers of oxidative stress measured in this study included ox-LDL and MPO. 
Green tea catechins (primarily EGCG) may play a role in the inhibition of LDL 
oxidation. Miura et al., 2000 reported that tea polyphenols inhibited the oxidation of 
LDL. With regards to ox-LDL there was a significant decrease in the green tea beverage 
group at 8 weeks when compared to baseline (p<0.05). However, this decrease in the 
green tea group was non-significant in comparison to controls. Furthermore, a non-
significant increase in ox-LDL was seen in the supplement group at 8 weeks when 
compared to baseline. A 42 day study by Erba et al., 2005 that involved 24 healthy 
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females found a slight decrease in LDL as compared to the control group and an 
improved plasma antioxidant status. Furthermore, Serafini et al., 2000 found that green 
tea showed a maximum decrease in LDL oxidation 30 minutes after ingestion.      
Green tea group showed a decreasing trend in MPO levels compared to controls. 
This may be an indication that (with a longer study duration) green tea beverage may 
show a significant decrease in MPO levels when compared to controls. The supplement 
group showed no significant decrease in MPO levels while the controls showed a non-
significant increase in MPO levels.  
When analyzing ox-LDL and MPO levels at baseline, 4 weeks and 8 weeks, green 
tea beverage seemed to have the greatest reducing effects on the biomarkers of oxidative 
stress. There was a significant decrease within the green tea beverage group in both ox-
LDL (when compared to baseline) and MPO (when compared to supplement). This 
shows that green tea beverage may have a greater positive effect on biomarkers of 
oxidative stress compared to the supplement group and controls. Therefore, freshly 
brewed green tea may have a greater bioavailability than encapsulated green tea extract. 
However, the supplement did show a non-significant decrease in MPO which, if the study 
were extended, may have been significant. The use of medication should be taken into 
account when analyzing the results from any of the clinical parameters measured in this 
study. Previous clinical trials have not investigated the effects of green tea flavonoid 
supplement on MPO levels. Thus, to our knowledge this is a unique finding of decreasing 
trend in MPO levels following green tea flavonoid supplement.    
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Limitations 
The small sample size in the present study in conjunction with the short duration 
of the study is a limitation of the current study. This may also account for the trends that 
did not reach significance. A larger sample size and longer study duration in future 
clinical trials on green tea intervention may improve findings and better show the effects 
of green tea beverage and supplement on subjects with MeS.   
 Compliance and lifestyle changes are possible limitations to this study. Even 
though pill counts were administered and there was monitoring of green tea beverage 
consumption, there was no monitoring of compliance outside GCRC. Subjects were 
instructed to maintain their typical physical activity patterns. However, physical activity 
was not monitored and lifestyle changes could have been made outside the GCRC. 
 Along with compliance and lifestyle changes, medication use is another possible 
limitation of this study. The benefits of green tea beverage and/or supplement may have 
been masked by medication use and this may have affected the parameters tested. Future 
studies need to address the interactions of green tea beverage and supplement in 
conjunction with medication use.   
 
Implications for Future Practice and Research 
  
 This clinical trial showed that the daily consumption of up to 4 cups/day of 
freshly brewed green tea is safe for use in individuals with MeS. Furthermore, it was 
shown that intake of 500 mg EGCG/day is safe for use in individuals with MeS. A longer 
study duration may have shown more significant changes on hematology and safety 
parameters. Green tea beverage decreased ox-LDL significantly at 8 weeks when 
compared to baseline (p<0.05) and the green tea group showed a decreasing trend in 
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MPO levels compared to controls. Additional research is needed to determine the effects 
of green tea supplementation on biomarkers of oxidative stress in subjects with MeS and 
determine the differences in bioavailability of green tea beverage and supplementation. 
Future studies on subjects not on stable medication may show a different result on the 
clinical parameters measured.    
Hypotheses 
 
The present study looked at the correlation between chronic green tea 
supplementation and its effects on hematological profile, safety parameters and oxidative 
stress in subjects with MeS. The null hypotheses tested, both of which we reject, included 
the following: 
• Green tea extract supplementation or green tea beverage will have no 
effects on safety parameters in individuals with MeS. We reject the null 
hypothesis. There was a significant change in platelets (p<0.05) in the 
supplement group versus control.    
• Green tea extract supplementation of green tea beverage will not lower 
biomarkers of oxidative stress in subjects with MeS. We reject the null 
hypothesis. Ox-LDL decreased in the green tea group significantly versus 
baseline (p<0.05); decreasing trend in MPO in green tea groups vs 
controls.  
Conclusion  
 According to the findings of this study, freshly brewed green tea and green tea 
supplement is safe for use in middle-aged obese adults with MeS and green tea beverage 
was shown to lower biomarkers of oxidative stress. A decreasing trend was shown with 
 38 
regards to MPO when analyzing the effects of the supplemented group. Although this 
group did not reach statistical significance, a longer study duration may have presented 
different results. In addition, it is possible that the decreasing trend in MPO levels and 
ox-LDL would have reached a greater statistical significance in both the green tea 
beverage group and a statistical significance in the supplement group with the use of a 
larger sample and longer study duration. Thus, it can be concluded that green tea 
beverage and supplement may provide safe effective means of improving features of MeS 
and decreasing oxidative stress in these subjects.   
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